Drug name - Morphabond Er
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10314788 | DAIICHI SANKYO INC | Pharmaceutical compositions configured to deter dosage form splitting |
Aug, 2028
(5 years from now) | |
| US7955619 | DAIICHI SANKYO INC | Abuse resistant drugs, method of use and method of making |
Aug, 2028
(5 years from now) | |
Drugs and Companies using MORPHINE SULFATE ingredient
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 15MG | TABLET, EXTENDED RELEASE;ORAL | Discontinued |
| 30MG | TABLET, EXTENDED RELEASE;ORAL | Discontinued |
| 60MG | TABLET, EXTENDED RELEASE;ORAL | Discontinued |
| 100MG | TABLET, EXTENDED RELEASE;ORAL | Discontinued |
availability in other generic markets.
Click on the highlighted region to filter.